To assess the functionality of nAbs and their capacity to form stable immunocomplexes across various diseases, we analyzed the binding affinity of anti-αSyn, -Aβ, and -tau IgG nAbs in patients with AD, DLB and PD, as well in control individuals. The gene discussed is MAPT; the disease is Alzheimer disease.